USA - NASDAQ:APYX - US03837C1062 - Common Stock
We assign a fundamental rating of 2 out of 10 to APYX. APYX was compared to 190 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of APYX have multiple concerns. APYX is quite expensive at the moment. It does show a decent growth rate.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -29.66% | ||
ROE | -237.96% | ||
ROIC | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 61.63% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 4.74 | ||
Debt/FCF | N/A | ||
Altman-Z | 0.15 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 4.72 | ||
Quick Ratio | 3.95 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | N/A | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
NASDAQ:APYX (10/20/2025, 8:00:00 PM)
3.13
+0.21 (+7.19%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A | ||
P/S | 2.55 | ||
P/FCF | N/A | ||
P/OCF | N/A | ||
P/B | 16.32 | ||
P/tB | 16.32 | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -29.66% | ||
ROE | -237.96% | ||
ROCE | N/A | ||
ROIC | N/A | ||
ROICexc | N/A | ||
ROICexgc | N/A | ||
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 61.63% | ||
FCFM | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 4.74 | ||
Debt/FCF | N/A | ||
Debt/EBITDA | N/A | ||
Cap/Depr | 129.14% | ||
Cap/Sales | 1.54% | ||
Interest Coverage | N/A | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 4.72 | ||
Quick Ratio | 3.95 | ||
Altman-Z | 0.15 |